Biosimilar Regulatory solution center
-
Navigating Outsourced Pharmaceutical Testing Through Today's Geopolitical Uncertainty
10/22/2026
Geopolitical shocks are reshaping outsourced pharmaceutical testing. Learn how procurement teams can strengthen resilience and protect continuity.
-
Is Your Supply Chain Ready For The End Of Class VI?
10/21/2026
Revisions to USP <87> and <88> update biological reactivity testing — changes that are especially important for companies that rely on single-use technology.
-
DEA Reveals Hidden Costs Of Analytical Validation Guidelines
10/2/2026
By treating distinct validation guidelines as decision-making units, data envelopment analysis (DEA) allows for the mathematical evaluation of their resource efficiency.
-
FDA Modernizes Container Closure Guidance: What Is Changing And Why It Matters
10/1/2026
The proposed revision reflects changes in packaging technology, drug delivery systems, quality risk management, and more that have occurred since 1999's guidance.
-
How Does SUS Integrity Change Across The Drug Product Lifecycle?
9/24/2026
Learn how phase-appropriate risk justification, validation, documentation, and lifecycle controls can strengthen sterility assurance while reducing the potential for rework and delays.
-
Can Targeted LNP Delivery Take In-Vivo CAR-T Therapy Beyond The Liver?
9/17/2026
Achieving successful extrahepatic CAR T delivery with LNPs requires addressing the unique biological and technological barriers and designing targeting approaches that leverage innovative LNP design.
-
Building Trust In AI For Computerized System Validation
9/4/2026
Using AI for CSV might feel like the students are grading their own papers. One consultant explains why it's not the same, namely, there are no subjective judgment calls.
-
Controls For Retrieval-Augmented Generation In GxP
9/1/2026
Validation teams deal with inherent variability all the time. The same principles for GMP — think visual inspection — can apply to probabilistic AI systems.
-
Implementing AI Solutions In GMP While Managing Risk
8/28/2026
When using artificial intelligence in GMP settings, risk management extends far beyond validation. This discussion explores moving AI solutions out of the pilot phase.
-
Chromatography Equipment Maintenance In An Era Of Acceleration
8/19/2026
As chromatography systems become more sophisticated, maintenance directly influences uptime. Learn why coordinated maintenance strategies are essential for supporting complex analytical work.